Is Galectin Therapeutics Inc. (GALT) a Buy, Sell, or Hold?
Galectin Therapeutics Inc.
NASDAQ:GALT
$4.76 USD
-$0.58 (-10.86%)
- Volume
- 528.8K
- Average Volume
- 609.99K
- Market Capitalization
- $313.48M
- P/E Ratio
- -11.70
- Dividend Yield
- 0.00%
- Price Target
- $11.00
- Year High
- $7.13
- Year Low
- $2.03
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.15
GALT vs. The Competition
| Properties | GALT | ALT | AURA | DMAC |
|---|---|---|---|---|
| Market Cap | $313.48M | $263.01M | $450.04M | $411.67M |
| Shares Outstanding | $65.86M | $88.26M | $64.2M | $53.88M |
| P/E Ratio | -11.7 | -3.2 | -3.96 | -10.76 |
| EPS | -0.4 | -0.73 | -1.67 | -0.65 |
| Day Low | 4.74 | 2.885 | 6.865 | 7.32 |
| Day high | 5.33 | 3 | 7.055 | 7.665 |
| Year Low | 2.03 | 2.56 | 4.73 | 3.65 |
| Year High | 7.13 | 6.44 | 9.535 | 10.4195 |
| Average Price 50 | 3.0816 | 2.9182 | 7.2142 | 6.358 |
| Average Price 200 | 3.70975 | 3.82668 | 6.31445 | 7.2029 |
| Volume | 528.8K | 2.83M | 304.32K | 158.62K |
| Average Volume | - | - | - | - |